During the progression of type 2 diabetes, β-cells fail and a subset lose features associated with their identity including reduced expression of key transcription factors (TFs). Among these is Pdx1, which is necessary for maintaining β-cell function and identity by controlling the expression of numerous β-cell genes including insulin, MafA, Glut2, and Ucn3. Pdx1, like most TFs, depends on the recruitment of coregulators to modulate its transcriptional activity. Numerous Pdx1-interacting proteins have been identified including Chd4, an ATP-dependent helicase of the chromatin remodeling NuRD complex. NuRD controls cellular processes including maintenance of cellular identity and mitochondrial function in a variety of tissues. The role Chd4 plays in modulating Pdx1 activity in the β-cell has yet to be explored. In this study, we performed co-immunoprecipitation and proximity ligation assay (PLA) in the Min6 murine insulinoma β-cell line and PLA in 8-week old C57BL/6 mouse pancreatic tissue, confirming Chd4:Pdx1 interactions in the nuclei of β-cells in both cell lines and tissue. Transient, RNAi-mediated knockdown of Chd4 in mouse β-cell lines altered the expression of Pdx1-regulated genes involved in β-cell function and identity including the MafA TF, which was reduced at both the RNA (41% ± 3 (p < 0.05)) and protein level. Moreover, the nuclear-encoded mitochondrial Tfam TF (reduced 30% ± 10 (p = 0.09)), the mitochondrial Mipep enzyme (reduced 35% ± 18 (p = 0.10)), and pre-Ins2, the unprocessed Ins2 transcript (reduced 38% ± 9 (p = 0.13)) were also altered, although they did not reach significance. These data suggest that Chd4 plays an important role in modulating the expression of genes controlled by Pdx1 in the β-cell. Future efforts are focused on further characterizing the role of Chd4 in the β-cell with CRISPR/Cas9 Chd4 knockout β-cell lines in vitro and β-cell specific Chd4 knockout mice.

Disclosure

R.K. Davidson: None. N. Casey: None. J. Spaeth: None.

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (K01DK115633)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.